The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,331,313 in first-year total cost, median $665,657.
Most frequent study sections
- Special Emphasis Panel[ZHL1 CSR-C (S1)]2
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
- PENNSYLVANIA STATE UNIV HERSHEY MED CTR1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Treatment of Fentanyl Overdose-Induced Respiratory Failure by Low-Dose Dexmedetomidine1R61HL156248-01 | HAOUZI, PHILIPPE A | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $708,424 | ZHL1 |
| 2020 | Intranasal Leptin as A Novel Treatment of Opioid-Induced Respiratory Depression1R61HL156240-01 | POLOTSKY, VSEVOLOD Y | JOHNS HOPKINS UNIVERSITY, MD | $622,889 | ZHL1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.